Literature DB >> 8206526

Transcriptional suppression of HLA-B expression by c-Myc is mediated through the core promoter elements.

L T Peltenburg1, P I Schrier.   

Abstract

In melanoma, HLA class I expression is suppressed by overexpression of the c-myc oncogene. This suppression has severe consequences for the recognition of these tumor cells by the immune system of the organism. We show here that transcription of the HLA-B locus, which is mainly affected by c-Myc, is downmodulated at the level of initiation of transcription. The transcriptional activity of various HLA-B reporter constructs was tested in a melanoma cell line with low endogenous c-myc expression and in transfectants with high stable and transient c-myc expression. We demonstrated that the responsive region can be mapped to the core promoter region of HLA class I, ruling out any effects of c-myc overexpression on the enhancer A or enhancer B regions. The region subject to downregulation is confined to a 43 base pair fragment encompassing the CCAAT and TATA elements. By coupling this region to a heterologous viral enhancer, we showed that the downmodulation by c-Myc is independent of the presence and nature of an enhancer. These results suggest a mechanism in which c-Myc downregulates the expression of HLA class I genes by interfering with the basal level of transcription.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8206526     DOI: 10.1007/bf00163964

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  60 in total

Review 1.  Diverse transcriptional functions of the multisubunit eukaryotic TFIID complex.

Authors:  B F Pugh; R Tjian
Journal:  J Biol Chem       Date:  1992-01-15       Impact factor: 5.157

2.  Yeast and human TATA-binding proteins have nearly identical DNA sequence requirements for transcription in vitro.

Authors:  C R Wobbe; K Struhl
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

3.  The complete primary structure of HLA-Bw58.

Authors:  J P Ways; H L Coppin; P Parham
Journal:  J Biol Chem       Date:  1985-10-05       Impact factor: 5.157

4.  Organization, sequence and expression of the HLA-B27 gene: a molecular approach to analyze HLA and disease associations.

Authors:  E H Weiss; W Kuon; C Dörner; M Lang; G Riethmüller
Journal:  Immunobiology       Date:  1985-12       Impact factor: 3.144

5.  Altered binding of regulatory factors to HLA class I enhancer sequence in human tumor cell lines lacking class I antigen expression.

Authors:  O Blanchet; J F Bourge; H Zinszner; A Israel; P Kourilsky; J Dausset; L Degos; P Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

6.  Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max.

Authors:  B Amati; S Dalton; M W Brooks; T D Littlewood; G I Evan; H Land
Journal:  Nature       Date:  1992-10-01       Impact factor: 49.962

7.  Suppression of MHC class I RNA in highly oncogenic cells occurs at the level of transcription initiation.

Authors:  N Lassam; G Jay
Journal:  J Immunol       Date:  1989-12-01       Impact factor: 5.422

8.  The MYC protein activates transcription of the alpha-prothymosin gene.

Authors:  M Eilers; S Schirm; J M Bishop
Journal:  EMBO J       Date:  1991-01       Impact factor: 11.598

9.  Suppression of MHC class I gene expression by N-myc through enhancer inactivation.

Authors:  M Lenardo; A K Rustgi; A R Schievella; R Bernards
Journal:  EMBO J       Date:  1989-11       Impact factor: 11.598

10.  N-myc disrupts protein kinase C-mediated signal transduction in neuroblastoma.

Authors:  R Bernards
Journal:  EMBO J       Date:  1991-05       Impact factor: 11.598

View more
  5 in total

1.  Sequence and Phylogenetic Analysis of the Untranslated Promoter Regions for HLA Class I Genes.

Authors:  Veron Ramsuran; Pedro G Hernández-Sanchez; Colm O'hUigin; Gaurav Sharma; Niamh Spence; Danillo G Augusto; Xiaojiang Gao; Christian A García-Sepúlveda; Gurvinder Kaur; Narinder K Mehra; Mary Carrington
Journal:  J Immunol       Date:  2017-02-01       Impact factor: 5.422

2.  Sequence polymorphism in the HLA-B promoter region.

Authors:  Z Yao; A Volgger; S Scholz; E D Albert
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

3.  Genetic and Environmental Determinants of Immune Response to Cutaneous Melanoma.

Authors:  Joanna Poźniak; Jérémie Nsengimana; Jonathan P Laye; Sally J O'Shea; Joey Mark S Diaz; Alastair P Droop; Anastasia Filia; Mark Harland; John R Davies; Tracey Mell; Juliette A Randerson-Moor; Sathya Muralidhar; Sabrina A Hogan; Sandra Nicole Freiberger; Mitchell P Levesque; Graham P Cook; D Timothy Bishop; Julia Newton-Bishop
Journal:  Cancer Res       Date:  2019-02-17       Impact factor: 12.701

Review 4.  c-Myc oncoprotein: a dual pathogenic role in neoplasia and cardiovascular diseases?

Authors:  Claudio Napoli; Lilach O Lerman; Filomena de Nigris; Vincenzo Sica
Journal:  Neoplasia       Date:  2002 May-Jun       Impact factor: 5.715

5.  nSARS-Cov-2, pulmonary edema and thrombosis: possible molecular insights using miRNA-gene circuits in regulatory networks.

Authors:  P Khurana; A Gupta; R Sugadev; Y K Sharma; R Varshney; L Ganju; B Kumar
Journal:  ExRNA       Date:  2020-10-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.